Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01171599 · ClinicalTrials.gov registry record · NA

PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia

A NA study of Obesity and Overweight, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01171599 is a NA study of Obesity and Overweight that has completed, run by University of California, San Diego. The registered enrollment target is 12 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01171599, a NA study of Obesity and Overweight, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this National Cancer Institute (NCI) funded study is to develop and test the acceptability and usability of a web \& text message based weight loss intervention for childhood acute lymphoblastic leukemia (ALL) survivors. Childhood cancer survivors ages 7 - 18 will provide feedback during focus groups on a web and text message based program that was developed.

Interventions

  • BEHAVIORAL Fit4Life

Study Locations (1)

California

  • UCSD, Atkinson Hall, 3rd Floor - La Jolla

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2008-08
Est. Completion 2011-08
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT01171599

The ClinicalTrials.gov registry entry for NCT01171599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Fit4Life is the first listed.

NCT01171599 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01171599 about?

NCT01171599 is a clinical study titled "PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia". The purpose of this National Cancer Institute (NCI) funded study is to develop and test the acceptability and usability of a web \& text message based weight loss intervention for childhood acute lymphoblastic leukemia (ALL) survivors. Childhood cancer survivors ages 7 - 18 will provide feedback dur...

What is the current status of trial NCT01171599?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2008-08. Estimated completion is 2011-08.

What conditions does trial NCT01171599 study?

This clinical trial studies the following conditions: Obesity, Overweight, Weight Loss, Weight Maintenance.

What interventions are being tested in trial NCT01171599?

The interventions under investigation include: Fit4Life (BEHAVIORAL).

Who is sponsoring clinical trial NCT01171599?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01171599 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.